Cardiovascular And Neurologic Applications Of Biomarkers

Abstract

Biomarkers are inexpensive, repeatable, and accessible diagnostic tools. Recent research has focused on their well-known benefits. Cardiovascular and neurological illnesses share risk factors and pathogenic pathways, affecting biomarker use and interpretation. Neurological illnesses affect hs-TroponinT, CK-MB, and NTproBNP. Galectin-3, lysophosphatidylcholine, copeptin, sST2, S100B, myeloperoxidase, and GDF-15 have been studied as cardiovascular and neurology alternatives. Due to their limited specificity, values require clinical judgement and additional tests.